Post job

Epharmix's revenue is $480,000.

What is Epharmix's revenue?

Epharmix's annual revenue is $480.0K. Zippia's data science team found the following key financial metrics about Epharmix after extensive research and analysis.
  • Epharmix peak revenue was $480.0K in 2024.
  • Epharmix has 30 employees, and the revenue per employee ratio is $16,000.

On this page

Peak revenue
$480,000 (2024)
Company peak revenue
Revenue / employee
$16,000
Company revenue / employee

Zippi applies for you, and finds you a job.

Floating question marks illustration
Peak revenue
$480,000 (2024)
Company peak revenue
Revenue / employee
$16,000
Company revenue / employee

Epharmix financing

Epharmix received early financing of $765.0K on 2015-07-13.

SeriesRound sizeDate
Debt Financing$765K07/2015
Series Unknown$1.9M09/2018

Epharmix investors

InvestorsSecurity type
Service Provider CapitalSeries Unknown

Epharmix competitors

Epharmix's top competitor, tamigo, earned an annual revenue of $15.0M.

Epharmix's smallest competitor is Innotrieve with revenue of $284.9K last year.

Company nameAverage salaryRevenueEmployee sizeJob openings
tamigo-$15.0M175-
Innotrieve-$284.9K1-
Maven Machines-$1.5M66-
Measurabl-$6.6M93-
AgSquared-$3.5M8-
Onovative-$5.0M11-
Pyze-$5.0M30-
Cosaic-$370,0006-
Eduplanet21-$930,00017-
Bricata-$1.1M39-

Epharmix revenue FAQs

Search for jobs

Zippia gives an in-depth look into the details of Epharmix, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Epharmix. The employee data is based on information from people who have self-reported their past or current employments at Epharmix. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Epharmix. The data presented on this page does not represent the view of Epharmix and its employees or that of Zippia.

Epharmix may also be known as or be related to Epharmix, Epharmix Inc and Epharmix, Inc.